Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article

The NOX Family of Proteins Is Also Present in Bacteria

Christine Hajjar, Mickaël V. Cherrier, Gaëtan Dias Mirandela, Isabelle Petit-Hartlein, Marie José Stasia, Juan C. Fontecilla-Camps, Franck Fieschi, Jérôme Dupuy
Richard Gerald Brennan, Editor
Christine Hajjar
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mickaël V. Cherrier
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaëtan Dias Mirandela
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Petit-Hartlein
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie José Stasia
b Univ. Grenoble Alpes, CNRS, TIMC-IMAG, 38000 Grenoble, France
c CDiRec, Pôle Biologie, CHU of Grenoble Alpes, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Fontecilla-Camps
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franck Fieschi
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérôme Dupuy
a Univ. Grenoble Alpes, CEA, CNRS, IBS, 38000 Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Gerald Brennan
Duke University School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.01487-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Transmembrane NADPH oxidase (NOX) enzymes have been so far only characterized in eukaryotes. In most of these organisms, they reduce molecular oxygen to superoxide and, depending on the presence of additional domains, are called NOX or dual oxidases (DUOX). Reactive oxygen species (ROS), including superoxide, have been traditionally considered accidental toxic by-products of aerobic metabolism. However, during the last decade it has become evident that both O2•− and H2O2 are key players in complex signaling networks and defense. A well-studied example is the production of O2•− during the bactericidal respiratory burst of phagocytes; this production is catalyzed by NOX2. Here, we devised and applied a novel algorithm to search for additional NOX genes in genomic databases. This procedure allowed us to discover approximately 23% new sequences from bacteria (in relation to the number of NOX-related sequences identified by the authors) that we have added to the existing eukaryotic NOX family and have used to build an expanded phylogenetic tree. We cloned and overexpressed the identified nox gene from Streptococcus pneumoniae and confirmed that it codes for an NADPH oxidase. The membrane of the S. pneumoniae NOX protein (SpNOX) shares many properties with its eukaryotic counterparts, such as affinity for NADPH and flavin adenine dinucleotide, superoxide dismutase and diphenylene iodonium inhibition, cyanide resistance, oxygen consumption, and superoxide production. Traditionally, NOX enzymes in eukaryotes are related to functions linked to multicellularity. Thus, the discovery of a large family of NOX-related enzymes in the bacterial world brings up fascinating questions regarding their role in this new biological context.

IMPORTANCE NADPH oxidase (NOX) enzymes have not yet been reported in bacteria. Here, we carried out computational and experimental studies to provide the first characterization of a prokaryotic NOX. Out of 996 prokaryotic proteins showing NOX signatures, we initially selected, cloned, and overexpressed four of them. Subsequently, and based on preliminary testing, we concentrated our efforts on Streptococcus SpNOX, which shares many biochemical characteristics with NOX2, the referent model of NOX enzymes. Our work makes possible, for the first time, the study of pure forms of this important family of enzymes, allowing for biophysical and molecular characterization in an unprecedented way. Similar advances regarding other membrane protein families have led to new structures, further mechanistic studies, and the improvement of inhibitors. In addition, biological functions of these newly described bacterial enzymes will be certainly discovered in the near future.

INTRODUCTION

Oxidative stress occurs when the balance between the generation of free radicals and their removal by antioxidants is lost. Free radicals are normally generated in the human body by metabolic processes, the best known being superoxide, peroxide, and radical hydroxyl oxygen species, which are collectively called reactive oxygen species (ROS). These species, which are highly reactive and can attack proteins, lipids, and nucleic acids, are major contributors to damage in biological organisms (1). These damages include aging-associated pathologies, cardiovascular disease, neurological disorders, fatty liver disease, cancers, and chronic inflammation (2). However, it is also apparent that ROS play essential roles in normal physiological processes, such as redox regulation, brain physiology, blood pressure, cell differentiation, hormone synthesis, and the very well-documented host defense system (3, 4). ROS-producing systems include xanthine oxidase, the mitochondrial respiratory chain, peroxidases, cytochrome P450 enzymes, uncoupled endothelial NO synthase, and phagocytic NADPH oxidases (NOXs). NOX proteins were the first identified systems that generate ROS not as a by-product but rather in a dedicated and targeted manner.

Eukaryotic NOXs are generally known to catalyze one-electron transmembrane transfer to molecular oxygen, resulting in the synthesis of superoxide anion, the initial ROS. Historically, gp91phox, the NADPH oxidase from phagocytes and now called NOX2, was the first NOX described to produce ROS during the respiratory burst of the innate immunity process (5–10). Its first homolog was found in 1996 in rice (11), and within a few years five other NOXs were identified in mammals (6, 10, 12–17). The NOX family was subsequently divided into three subgroups, depending on the presence or absence of additional domains associated with the NOX2 protein core. They are widely distributed, tissue-specific modular proteins that share, for NOX1 to -4, a core consisting of a ferredoxin-NADP+ reductase (FNR)–like domain (9) and a membrane-bound ferric reductase-like domain (FRD) called the YedZ domain in prokaryotes (18, 19) (Fig. 1A). They may also have, like NOX5, EF-hand domains and, in addition, as for dual oxidase 1 (DUOX1) and DUOX2, an amino-terminal peroxidase homology segment (3) (Fig. 1A). Besides NOX2, which is found in phagocytes, cardiac tissue and brain, where it is involved in host defense, muscle contraction, and neural degeneration, respectively (20), NOX enzymes from nonimmune tissues are involved in processes such as cell proliferation, apoptosis, and receptor signaling (3). Conversely, DUOX enzymes are implicated in reactions that involve extracellular matrix proteins, such as reactions for thyroid hormone synthesis (21, 22).

FIG 1 
  • Open in new tab
  • Download powerpoint
FIG 1 

(A) Schematic representation of the NOX/DUOX protein family. (B) Multiple-sequence alignment of human NOX and DUOX proteins. Only the motifs used in this study are displayed. Amino acids strictly and partially conserved are highlighted in red and yellow, respectively. (C) Chart of the different filters used in this study to identify NOX sequences from Fasta formatted sequences. Each filter is independent and can be used separately.

Blocking the undesirable actions of NOX enzymes is a strategy for treating oxidative stress-related pathologies and damage. In addition to ROS-provoked damage, deregulation of NOX-dependent ROS production can have pathological consequences related to a specific physiological context (e.g., chronic granulomatous disease, autoimmune disorders, hypothyroidism when ROS production is impaired, or cardiovascular and neurodegenerative diseases in the case of ROS overproduction) (21, 23).

Traditionally, the presence of NOX enzymes has been linked to functional requirements related to multicellularity (24). An exception is the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, which are unicellular organisms known to contain open reading frames (ORFs) homologous to NOX in its genome. However, except in one case (25), these ORFs have not been described as NOXs but as ferric reductases (FRE) (26). FRE and NOX enzymes have different final electron acceptors, O2- and Fe3+-chelating complexes, respectively, which are attributed to a few amino acid sequence changes within their FRD. Nevertheless, they have been traditionally placed within the same global protein family in phylogenetic analyses (18, 27). Although both FNR and YedZ, the model of bacterial FRD protein recently renamed MsrQ (18, 19, 28), are found separately in prokaryotes, the presence of functional nox genes in bacterial genomes containing both domains has not been established (29).

RESULTS

Computational screening of putative NOX sequences.An algorithm was devised to search for bacterial NOX sequences, using only the following essential eukaryotic motifs: (i) NADPH- and FAD-binding domains, both NOX specific, and (ii) two heme-binding His-X12/14-His sequences (Fig. 1B). These filters were introduced to keep only sequences of proteins of interest for the next step. The final filter included the selection of bis-hystidyl patterns separated by at least 20 amino acids, which is the average length of a transmembrane α-helix, as well as a predicted transmembrane domain with at least three α-helices (Fig. 1C). The latter condition was used because the cytochrome b-like domain, which consists of six α-helices, is expected to bind the two-heme moieties at helices number 3 and 5. Starting from the 78,037,012 ORFs found in the UniprotKB/Swiss-Prot and UniProt/TrEMBL databases, our algorithm selected 4,404 putative NOX amino acid sequences from 1,492 different organisms, over a third of which were bacteria (Table 1). Conversely, only one archaeal sequence was found that fulfilled all of the above selection criteria (Fig. 1C). Subsequently, we selected a smaller set of sequences from all the represented domains of life (see Table S2 in the supplemental material) by removing (i) sequences from related organisms with >99% homology and (ii) a few sequences where the above motifs were not correctly aligned. Finally, 162 ORFs were selected to build an extended phylogenetic tree for the NOX/FRE family (see Table S3 in the supplemental material). The tree (Fig. 2) shows a clear division between eukaryotes and prokaryotes, which may have evolutionary significance.

View this table:
  • View inline
  • View popup
TABLE 1 

Statistical analysis results from the search for NOX sequences in the UniProt databasea

FIG 2 
  • Open in new tab
  • Download powerpoint
FIG 2 

Phylogenetic tree of the NOX family. The tree was constructed using 162 sequences out of the 4,404 sequences identified in this study, and the sequences came from genera representative of all life domains (56). Eukaryote and prokaryote sequences are shown in red and blue, respectively. The green star highlights the only prokaryote sequence present in a eukaryote branch of the tree. The purple star highlights the unique eukaryote sequence present in the prokaryote branch of the tree. Each subfamily is indicated by blue square brackets. SpNOX is displayed in orange.

Selection of membrane protein candidates from bacterial genomes.In order to confirm that the sequences we extracted from bacterial genomes corresponded to functional NOX enzymes, we selected genes from Acaryochloris marina, Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae (AmNOX, EcNOX, PaNOX, and SpNOX, respectively) for further characterization. Their predicted protein topologies are very similar to the one calculated for NOX2, except for AmNOX, which is closer to NOX5 (Fig. S1). The selected genes were cloned and overexpressed in E. coli (Fig. S2), and the determination of the integrity of the resulting proteins was followed by spectrophotometry of the membrane extracts. Indeed, eukaryotic NOX enzymes are known to have a spectral signature with characteristic peaks at 426 nm and 558 nm in a difference (reduced minus oxidized) spectrum. The negative control was the same E. coli strain transformed by an expression plasmid devoid of a bacterial putative NOX gene. SpNOX, followed by PaNOX, were the proteins that showed the stronger spectroscopic signals (Fig. S3). Based on these results, we decided to pursue our study with SpNOX.

FIG S1 

The predicted topologies of NOX2, SpNOX, EcNOX, PaNOX, and AmNOX consist of six transmembrane helices with 4 conserved histidines (red circles) in the transmembrane domain, a NADPH-binding domain (purple circles), and a FAD-binding domain (green circles). Schemes were prepared using the Protter server. Download FIG S1, JPG file, 2.7 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG S2 

SDS-PAGE expression and Western blotting results (using an anti-His tag antibody) for four prokaryotic NOXs (see the main text for abbreviations). Four samples of each construct were characterized via SDS-PAGE prior to IPTG induction (t = 0) or after 1 h of induction (t = 1), 2 h of induction (t = 2), and 3 h of induction (t = 3). The black dot indicates the different expressed proteins. (Bottom panel) The Western blot results showed an expression leakage before induction. The problem was fixed with an E. coli strain containing a pLysS vector. Download FIG S2, JPG file, 2 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG S3 

Spectral characterization of membrane preparations from E. coli expressing SpNOX (red), PaNOX (blue), EcNOX (green), and AmNOX (orange). The control spectrum (gray) was obtained using an E. coli membrane preparation transformed with an expression vector devoid of the bacterial NOX genes. Download FIG S3, JPG file, 0.7 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

SpNOX exhibits a cytochrome b558 spectrum typical of NOX enzymes.SpNOX contained in the membrane preparation generated a spectrum similar to the one from NOX2. The dithionite-reduced difference spectrum showed a small peak at 558 nm, a shoulder at 530 nm, and a sharp peak at 426 nm (Fig. 3A) (30). As with many other cytochromes, the oxidized SpNOX gave a spectrum with a characteristic Soret band at 410 nm. The reduction of the heme b groups was followed by spectrophotometry, after the addition of NADPH. Increasing incubation times resulted in more pronounced peaks at 426 nm and 558 nm, while the spectrum decreased at 450 nm. These spectral changes indicate flavin reduction after electron transfer from NADPH (Fig. 3B) (31). Furthermore, heme reduction showed that electrons migrated from NADPH to the heme groups through the flavin cofactor, which is necessary to uncouple them (Fig. 3B).

FIG 3 
  • Open in new tab
  • Download powerpoint
FIG 3 

Enzymatic characterization of SpNOX. (A) Difference (reduced minus oxidized; solid line) and oxidized (dashed line) spectra from an E. coli membrane preparation expressing SpNOX. The typical peaks of NOX proteins are highlighted. (B) Absorbance spectra of a membrane preparation expressing SpNOX in the presence of 200 µM NADPH. Membrane reduction was sequentially recorded after 2 min (black line), 6 min (red line), and 10 min (blue line). Heme reduction was followed by an increase in peak height at 426 nm and 558 nm, showing that electrons can reach the membrane-bound core of SpNOX. (C) The activity of pure SpNOX was monitored in the presence or the absence of 2 µM FAD. (D and E) Michaelis-Menten saturation curves of SpNOX activity as a function of either NADPH concentration in the presence of 10 µM FAD (D) or FAD concentration in the presence of 200 µM NADPH (E). (F) NADPH oxidation (dashed line) and cytochrome c reduction (solid line) were followed simultaneously at 340 nm and 550 nm, respectively. (G) The reduction of cytochrome c (bold line) was inhibited by the addition of 0.3 mg/ml of SOD. (H) Inhibition effects of increasing SOD concentrations on SpNOX NADPH oxidase activity (n = 5). (I) SpNOX NADPH activity in either the presence (+) or absence (−) of O2; this experiment was performed under argon. (J) The predicted NOX2 and SpNOX topologies consist of six transmembrane helices with 4 conserved histidines (red circles) in the transmembrane domain, NADPH-binding site (green circles), and FAD-binding site (purple circles). The NOX2 glycosylation sites are shown as green squares. Schemes were prepared using the Protter server (http://wlab.ethz.ch/protter/start/ ) and the topologies were predicted by the TMHMM server (http://www.cbs.dtu.dk/services/TMHMM/ ).

SpNOX and NOX2 share enzymatic properties.A detergent screening was performed to identify the best-suited detergent to solubilize and stabilize SpNOX in an active form. The detergents of the maltoside family fulfilled all these requirements (Fig. S4). The His-tagged protein was found to be pure after its passage through a nickel affinity column followed by a size exclusion chromatographic step (Fig. S5). Next, the NADPH oxidase activity of the purified SpNOX was measured. It is well known that FAD is a required cofactor for the activity in eukaryotic NOX enzymes. Accordingly, the activity assay was performed with and without FAD, and superoxide production was determined by using a reporting system based on cytochrome c reduction. We found that purified SpNOX activity was dependent on FAD supplementation (Fig. 3C). However, the kinetic activity was strictly proportional to the final protein concentration, confirming that this activity is generated by an enzymatic process (Fig. S6A and B). SpNOX has lower affinities for NADPH and FAD (Km of 8 µM and 0.13 µM) than NOX2 (Km of 25 to 50 µM and 1 nM) (32, 33) (Fig. 3D and E) (34). It also exhibited a specific activity of 19 mol O2•−/mol SpNOX/s, which represents 30% of that one reported for NOX2 (which is 64 mol O2•−/mol cytochrome b/s [35]). Conversely, SpNOX has about twice the estimated specific activity of NOX4 (36). The stoichiometry of the reaction was established by simultaneously following substrate oxidation and cytochrome c reduction (Fig. 3F). One NADPH molecule should be able to transfer two electrons, ultimately producing two superoxide ions. From the kinetics presented in Fig. 3F, we obtained between 1.4 and 1.6 reduced cytochrome c molecules per oxidized NADPH molecule. This ratio compared well with the theoretical maximum value of 2, with the deficit explained by incomplete O2•− scavenging by cytochrome c (37, 38). Moreover, replacement of His heme ligands in the H69A-H129A and H83A-H142A variants resulted in membrane fractions displaying the same basal activity level as the membrane fraction of E. coli transformed with the empty expression vector (Fig. S6C and D). Thus, the NADPH oxidase activity observed in SpNOX depends on electron transfer through the hemes and, consequently, it is not due to electron loss at the SpNOX FNR domain.

FIG S4 

Spectroscopic results for protein stability using different detergents. The spectral signature of the heme cofactor was used as a reporter of protein folding. The critical micellar concentrations (CMC) of +5 mM (solid line) and +20 mM (dashed line) were tested. The best detergents were DDM and Cymal 7. Unfortunately, the latter inhibited SpNOX activity. Subsequently, we used DDM and, finally, its dimeric version, MNG3, which gave the best results. Download FIG S4, JPG file, 1 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG S5 

Purification of SpNOX. The elution profile shows a symmetrical SpNOX peak after the last purification step (Superdex 200 gel filtration). The SDS-PAGE analysis (bottom inset) showed bands corresponding to the membrane fraction before solubilization (Mb), the sample loaded onto the nickel column (L), the flowthrough solution (FT), the washing solution (W) of the affinity step, and the protein that eluted from the size exclusion column. The affinity and size exclusion steps were coupled together, so only the samples before (L) and after (E) the purification procedure were analyzable. The presence of the heme cofactors in SpNOX produced a reddish color for the protein sample, which helped us follow it during purification. The purified protein sample was homogeneous, as confirmed by mass spectrometry. Download FIG S5, JPG file, 1.1 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG S6 

Supplemental enzymatic characterization. (A) The kinetic activity was followed at 550 nm at different final protein concentrations. (B) The initial velocities are plotted on the right side of the figure. The curve could be fit to a straight line. Each condition was assayed at least 3 times. (C) The NADPH oxidase activity assay was performed with the SpNOX with the histidine ligands of the hemes mutated to alanine (see main text). The activity assays were performed with membrane fractions overexpressing the mutants and were compared to the wild-type protein activity. (D) The expression of the mutants was checked by Western blotting. The quadruplet mutant (Q) is labeled. Download FIG S6, JPG file, 1.5 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

A superoxide dismutation assay showed O2•− production by SpNOX.Superoxide production was also demonstrated by addition of superoxide dismutase (SOD) to the reaction mixture, which decreased cytochrome c reduction kinetics to 60% (Fig. 3G and H). The remaining SOD-insensitive activity (40%) likely resulted from direct cytochrome c reduction by SpNOX. Indeed, similar assays carried out under an argon atmosphere confirmed the direct electron transfer from SpNOX to cytochrome c, albeit with lower efficiency (Fig. 3I). This result can be rationalized by comparing the topologies of NOX2 and SpNOX. The extracellular A, C, and E loops are significantly shorter in SpNOX than in NOX2. In the context of this in vitro assay, this topology difference may facilitate the access of cytochrome c to the external heme of SpNOX, closer to the extracellular side (Fig. 3J). Another possibility is the direct reduction by FAD, because both sides of SpNOX are accessible in the detergent-solubilized form of the protein.

Diphenylene iodonium inhibits SpNOX.DPI inhibits flavoenzymes such as NOX2 (36) and is widely used as a common inhibitor of NOX enzymes. The effect of DPI (39, 57) on SpNOX activity was evaluated in the cytochrome c reduction assay. Addition of DPI immediately stopped the reaction (Fig. 4A). This inhibitor reacts with reduced FAD to form a phenyl radical, which can either attack amino acids found at or near the FAD-binding site or directly attack the cofactor, ultimately resulting in irreversible enzyme inhibition (40). The calculated DPI 50% inhibitory concentration was around 5 µM for 1 µM FAD in our assay (Fig. 4B).

FIG 4 
  • Open in new tab
  • Download powerpoint
FIG 4 

NOX activity of SpNOX. (A) SpNOX activities were measured after adding NADPH and FAD to final concentrations of 200 µM and 10 µM, respectively. The enzymatic activity was inhibited by the addition of 50 µM DPI (arrow). (B) Percentage of NADPH oxidase activity inhibition when monitored at different DPI concentrations. The error bars correspond to the standard deviations (n = 3). (C and D) Soret peak-containing spectra of SpNOX before (solid line) and after (dashed line) cyanide addition. As with eukaryotic NOXs, cyanide had no effect on the enzymatic activity of SpNOX. (E) Kinetics of cyanide-insensitive oxygen consumption by SpNOX. Only DPI inhibited this process. (F) The reduction of the ferric iron (dashed line) was inhibited by the addition of 0.4 mg/ml of SOD.

Cyanide does not inhibit SpNOX activity.Cyanide is known to be a global inhibitor of hemoproteins, thanks to its axial binding to the iron ion. In contrast to this general rule, NOX enzymes are insensitive to both azide and cyanide; this feature represents a hallmark of NOX proteins, where both hemes are expected to be hexa-coordinated (6). We have also assessed this property for SpNOX by using catalase as a positive control. While cyanide incubation induced a shift of the 417 nm Soret band of catalase (data not shown), no modification was observed in the SpNOX spectrum upon NaCN addition (Fig. 4C). Furthermore, its NADPH oxidase activity was identical with or without added cyanide or azide (Fig. 4D). Finally, SpNOX-dependent oxygen consumption, measured using a Clark electrode (31) (Fig. 4E), confirmed its insensitivity to NaCN addition. Taken together, these data show that electrons transferred from NADPH to the heme groups through FAD can use molecular oxygen as the final acceptor. This activity, along with the DPI sensitivity and cyanide resistance described above, is indicative of the structural and functional relatedness of SpNOX to the eukaryotic NOX family of NADPH oxidases.

SpNOX is not a “true” ferric reductase.Within the global NOX/FRE family of enzymes harboring FRD and FNR domains, a distinction based on the final electron acceptor is often made between NOX/DUOX enzymes, which are capable of using oxygen as the electron acceptor, and FRE enzymes, which directly reduce the iron-chelating complex. In order to characterize further our bacterial NOX-related enzyme, we tested whether, in addition to its capacity to use oxygen as described above, SpNOX also had direct ferric reductase activity, as defined in a classical assay. We found that SpNOX was not able to reduce Fe3+ to Fe2+ in the presence of SOD (Fig. 4F). This showed that the observed ferric reductase activity of SpNOX is due to the produced superoxide ions that, in turn, are capable of reducing ferric iron. The specific activity was estimated to be 7.9 mol of Fe3+ reduced/mol of SpNOX/s, which represents 32% of NOX2’s ferric reductase activity. Indeed, the same experiment was performed using the human cytochrome b558, for which the specific activity was calculated to be 24 mol of Fe3+ reduced/mol of cytochrome b/s (data not shown). The SpNOX to NOX2 ratios of NADPH oxidase activity and ferric reductase activity were comparable, as expected from the dependency of the latter on the production of O2•− by the former. Thus, within the NOX/FRE family of enzymes, SpNOX appears to be more related to a NOX than to a FRE, as indicated by its in vitro reactivity.

DISCUSSION

Although new members of the NOX family of electron transfer membrane proteins have been continuously discovered since the 2000s, they have been restricted to eukaryotic organisms, from fungi to animals and plants. In 2004, a first indication of an evolutionary relationship of NOX enzymes with prokaryotic proteins was suggested by the simultaneous description by Von Rozycki et al. (19) and Sanchez-Pulido et al. (27) of the bacterial MsrQ protein. MsrQ was described as an FRD involved in electron transfer and significantly homologous to the membranous moiety of eukaryotic NOX proteins. Along the same lines, we reported recently that the flavin reductase Fre could be the potential electron donor to MsrQ. Thus, these two proteins mimic the architectural organization of eukaryotic NOX (38). This may be considered an intermediate evolutionary organization, ancestral to the eukaryotic NOX, where FRD and FNR domains are fused into a single polypeptide chain (38). The work presented here goes far beyond preliminary reports (19, 27), because we provide the first evidence for the existence of a large family of prokaryotic membrane proteins that have all the sequence motifs and predicted topological characteristics of NOX-related enzymes. All these prokaryotic sequences are well separated from their eukaryotic counterparts in the phylogenetic tree (Fig. 2). This suggests that they constitute a new subgroup in the NOX family of enzymes. A few bacterial sequences are located in the eukaryotic branches of the tree. These NOX5-like sequences, found, for instance, in Acaryochloris marina, were probably horizontally transferred from eukaryotic genomes (18). Moreover, there is one eukaryotic sequence from Anapheles coluzzii present in the middle of the bacteria subgroup. This sequence is very close to that in Chromobacterium sp., which is a bacterium that can effectively colonize the intestines of A. coluzzii (41). The horizontal gene transfer between bacteria and animals is still controversial and in this particular case it could have resulted from contamination during genome sequencing (42, 43). Thus, with the combinatorial use of specific sequence motifs characteristic of NOX enzymes, we have been able to identify a large number of bacterial sequences having (i) six transmembrane helices with (ii) conserved bis-histidyl motifs within the third and fifth transmembrane helices and (iii) a C-terminal dehydrogenase region containing FAD- and NADPH-binding domains.

This bioinformatics study was complemented with a biochemical characterization of the representative bacterial SpNOX, which fully confirmed its close functional and structural relationship with the eukaryotic NOX enzymes. Indeed, both systems are able to use NADPH as an electron donor and oxygen as the final acceptor. As expected, we also found that electron transfer from NADPH to O2 requires FAD and heme cofactors. Furthermore, like well-described NOX proteins, SpNOX is both sensitive to the DPI inhibitor, which targets the FAD moiety, and insensitive to cyanide.

In spite of the many common features, there are some clear differences between SpNOX and mammalian NOXs. Indeed, in contrast to NOX1 to -4, SpNOX does not need a p22phox-like subunit for proper membrane integration. Moreover, the purified recombinant form of the protein is constitutively active in vitro, without requiring cytosolic factors or an activation process. Also, SpNOX is active in a detergent-solubilized form, which is not the case for the mammalian NOX enzymes, which need to be reconstituted in a lipid bilayer (35, 44). Indeed, in order to be active, NOX2 needs to be reconstituted in a membrane forming a complex with cytosolic factors, lipid polar heads, and phosphatidylinositol, which is the template for p47phox binding and global assembly (45). Being independent from such an assembly process, SpNOX is fully functional when inserted in a detergent micelle. Thus, all in all, we believe that SpNOX is a good model to study the activated state of a mammalian NOX2-like enzyme. The recombinant production of SpNOX will allow for novel biophysical and biochemical studies of NOX-related membrane-bound enzymes.

Importantly, the presence of these enzymes in prokaryotes raises the question of what could be their function. The recent emergence of ROS as signaling molecules in eukaryotes has led to the concept of ROS signaling within and between cells (4, 20). An example of cross-cell communication is given by the slime mold Dictyostelium discoideum. Although it grows as a single amoeba when food is available, when starved the single cells aggregate, constituting a multicellular organism of up to a million amoebae, which forms a fruiting body that sporulates (46). The aggregate does not form if O2•− is scavenged either pharmacologically or by overexpression of SOD (46). Bloomfield et al. suggested that this (O2•−)-based signaling mechanism arose early in the evolution of multicellular organisms and most likely relies on NOXs, which genes are present in Dictyostelium (14) (Fig. 2). Indeed, Lardy et al. demonstrated the central role of NOX homologs in different phases of development of the slime mold (47).

Until now, it has been accepted that bacterial ROS production depends on reactions that are not primarily intended for that purpose. This apparent opportunistic, or even accidental, use of ROS appears to be in stark contrast with the regulated O2•− production by NOX and its possible transformation to H2O2 by SOD found in eukaryotes (2). Indeed, regulated ROS production is expected to be amenable to modulate intercellular signaling in a well-defined spatiotemporal context. In this context, our discovery that NOX-related enzymes are also present in bacteria (Fig. 2) is especially intriguing. Although, as far as we can tell, highly regulated generation of ROS in these microorganisms has not been reported, our results suggest that such process could be biologically important, for instance, for biofilm formation and dynamics. Indeed, bacterial biofilms, which are now known to be the most common way for bacteria to thrive in nature, have been considered an example of multicellularity (48). The use of NOX by bacterial communities could be a means to communicate within biofilms, as occurs in eukaryotes when O2•− is generated in processes such as protozoan cell aggregation or to mediate, along with H2O2, the many other ROS-dependent signaling processes known to take place in metazoans.

An alternative possibility is that, although our bioinformatics and biochemical analyses indicated that SpNOX is a bona fide “NADPH oxidase,” it may not necessarily function, in its bacterial physiological context, as the eukaryotic NOXs do. For instance, bacterial NOX-like proteins may be components of electron transfer pathways where O2 is not the physiological electron acceptor. A recent example of such a possibility is the discovery that MsrQ transfers its electrons to MsrP, a molybdopterin protein acceptor present in the periplasm of E. coli, to catalyze the reduction of methionine sulfoxide in oxidatively damaged periplasmic proteins (49). The observation that SpNOX can directly reduce cytochrome c demonstrates that its more exposed heme is accessible to potential periplasmic redox partners. This provides some support to the hypothesis of alternative electron acceptors for bacterial NOX proteins in general. We conclude that many new and unanticipated functions and synthetic pathways may turn out to be associated with this new family of bacterial NOX.

An SpNOX knockout of S. pneumoniae did not display an identifiable phenotype (data not shown). It is clear that further studies will be required to address the role of bacterial NOX in signaling and/or metabolic processes, as postulated above.

In conclusion, the work reported here has allowed us to identify for the first time, both theoretically and functionally, a significant number of bacterial protein sequences that are found in current databases and are counterparts of eukaryotic NOX proteins.

MATERIALS AND METHODS

NOX sequence identification.The software used to identify NOX sequences in bacterial genomes was written in Python 3.0. The program used three filters. The first two filters selected sequences containing H(PSA)F[TS][LIMV] (FAD-binding motif) and G(ISVL)G[VIAF][TAS][PYTA] (NADPH-binding motifs) (Fig. 1), defined using the 101 protein sequences identified by Kawahara et al. (50). The third filter selected sequences that contained the four histidine residues responsible for coordinating the two-heme moieties of the cytochrome b-like motif. The TMHMM sequence (51) was used to locate transmembrane α-helices. Sequences with more than seven predicted α-helices (the number found in DUOX1 and -2) were rejected, whereas sequences with at least 3 predicted α-helices were kept to account for errors in the prediction.

Amino acid sequence alignments and phylogenetic tree construction.Multiple sequence alignment of NOX sequences was carried out with Clustal Omega (52). The tree was built from 162 putative NOX sequences (Table S3) by using PhyML 3.0. The sequences used for software validation are provided in Table S1.

TABLE S1 

Sequences used for software validation (for each organism, the total number of sequences used and those selected by the software after each filter are shown; the NOX column shows the number of sequences from filter III that are NOX proteins; only NOX proteins were selected by the software for all the validation tests). Download TABLE S1, DOCX file, 0.03 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

TABLE S2 

List of the genera used to build the phylogenetic tree shown in Fig. 2. Download TABLE S2, DOCX file, 0.03 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

TABLE S3 

NOX prokaryotic sequences used to build the phylogenetic tree. Download TABLE S3, DOCX file, 0.04 MB.
Copyright © 2017 Hajjar et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

Cloning of the bacterial nox genes in a pQLink N vector.Genes were optimized for expression in E. coli and synthetized via GenScript. They were inserted in a pUC57 vector conferring ampicillin resistance and providing a His tag coding sequence in frame with the 5′ end of the inserted gene. The pUC57 vectors containing the bacterial nox genes were treated with Not1 and BamHI restriction enzymes for 2 h at 37°C and ligated to a NotI-BamHI-digested pQLink N vector to yield pQLink N-bacterial NOX expression plasmids. Several expression strains were tested, and the best result was obtained with BL21(DE3) pLysS expression cells.

SpNOX expression and purification.The culture was grown in LB medium containing chloramphenicol (0.034mg/ml) and ampicillin (0.1 mg/ml) at 37°C with shaking. At an optical density at 600 nm of 1.5, isopropyl-β-d-thiogalactopyanoside (IPTG) was added to a final concentration of 0.1 mM with shaking at 210 rpm to induce the expression of the protein of interest. After 4 h of induction, cells were harvested by centrifugation (7,000 × g, 30 min, 4°C).

The culture pellet was resuspended in 50 mM Tris-HCl (pH 7), 250 mM NaCl, 10% glycerol supplemented with DNase and an antiprotease cocktail. Cells were disrupted using a microfluidizer (M-1105; Microfluidics, USA) at 1,400 lb/in2 (4 to 5 passes). Unbroken cells, debris, and inclusion bodies were removed by one low-speed centrifugation step at 8,000  × g in a Beckman rotor 850 followed by ultracentrifugation at 235,000  × g (Beckman Ti-45 rotor at 45,000 rpm) for 45 min at 4°C. The resulting pellet of membranes was solubilized to 2 mg/ml in 50 mM Tris-HCl (pH 7), 300 mM NaCl, and 5 mM (0.5%) lauryl maltose neopentyl glycol (NG310-MNG). Equilibrated Ni-nitrilotriacetic acid (NTA)–Sepharose resin was added to the mixture (1 ml per 15 mg of protein) and incubated overnight with shaking at 4°C.

Loaded resin was packed in a gravity column and washed thoroughly with Tris-HCl buffer (pH 7), 300 mM NaCl, 0.015% MNG, and 50 mM imidazole. The same buffer supplied with 300 mM imidazole was used to elute the protein. Pure fractions were concentrated and loaded on a Superdex 200 column previously equilibrated with Tris buffer (pH 7.0), 300 mM NaCl, and 0.003% MNG. The protein sample was stored at 4°C.

Spectroscopy signatures.Differential (reduced minus oxidized) spectra were recorded between 600 and 400 nm using a Cary 50 Bio UV/visible spectrophotometer (6). Reaction mixtures (total volume of 130 µl in quartz cuvettes) consisted of membranes at 1 mg/ml. The spectrum of reduced protein was obtained after adding a few crystals of sodium dithionite.

NADPH oxidase activity assay.NADPH oxidase activity was assayed by following the reduction of cytochrome c (58). NADPH and FAD were added to 0.1 µg of protein to final concentrations up to 200 µM and 10 µM, respectively; the extent of cytochrome c (100 µM) reduction was calculated based on the absorbance difference at 550 nm with an absorption coefficient of 21,000 M−1 cm−1. DPI was added to a final concentration of 50 µM. Adding 10 units of superoxide dismutase verified the specificity of the product.

Measurement of cyanide-resistant oxygen consumption.The oxygen consumption rate of 20 µg of purified SpNOX was measured by using a Clark electrode in a final volume of 1.6 ml. The oxygraph was calibrated by addition of dithionite to air-saturated buffer to establish the zero level of O2 concentration. Sodium cyanide and DPI were added at final concentrations of 1 mM and 50 µM, respectively (54).

Ferric reductase activity assay.Ferrous ions form a complex with ferrozine, which can be monitored at 562 nm. The Fe-NTA solution was prepared as described by Awai et al. (55). The ferrozine stock solution was prepared in 150 mM of acetate buffer (pH 7) to a final concentration of 100 mM. Ferric reduction was calculated based on the absorbance difference at 562 nm, using an absorption coefficient of 28,000 M−1 cm−1 (53). The reaction mixture consisted of 0.1 µg/ml SpNOX, 0.4 mM ferrozine, 0.3 mM Fe-NTA, and 10 µM FAD, with the addition of 200 µM NADPH to a final volume of 1 ml to start the reaction.

ACKNOWLEDGMENTS

We are grateful to A. Picciocchi for his comments on an earlier version of the manuscript and C. Durmort for her help with the SpNOX knockout, and we thank Charlotte Genestet for technical help. This work used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UGA-EMBL) and notably the MP3 platform, with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology.

This work has been supported by a grant from the Joseph Fourier University (AGIR 2013—Grenoble, France). We also acknowledge support from the French Agence Nationale de la Recherche (ANR), under contract ANR-2010-1536-01 (Prototype Nox) and to the Programme Technology pour la Santé du CEA under contract A-TSANV-03-26 (BOSS).

FOOTNOTES

    • Received 17 August 2017
    • Accepted 27 September 2017
    • Published 7 November 2017
  • Copyright © 2017 Hajjar et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. D’Autréaux B,
    2. Toledano MB
    . 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol8:813–824. doi:10.1038/nrm2256.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Nathan C,
    2. Cunningham-Bussel A
    . 2013. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat Rev Immunol13:349–361. doi:10.1038/nri3423.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Lambeth JD
    . 2004. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol4:181–189. doi:10.1038/nri1312.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Mittler R,
    2. Vanderauwera S,
    3. Suzuki N,
    4. Miller G,
    5. Tognetti VB,
    6. Vandepoele K,
    7. Gollery M,
    8. Shulaev V,
    9. Van Breusegem F
    . 2011. ROS signaling: the new wave?Trends Plant Sci16:300–309. doi:10.1016/j.tplants.2011.03.007.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Babior BM,
    2. Kipnes RS,
    3. Curnutte JT
    . 1973. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest52:741–744. doi:10.1172/JCI107236.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Babior BM,
    2. Curnutte JT,
    3. Kipnes BS
    . 1975. Pyridine nucleotide-dependent superoxide production by a cell-free system from human granulocytes. J Clin Invest56:1035–1042. doi:10.1172/JCI108150.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Segal AW,
    2. Jones OT
    . 1978. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature276:515–517. doi:10.1038/276515a0.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Royer-Pokora B,
    2. Kunkel LM,
    3. Monaco AP,
    4. Goff SC,
    5. Newburger PE,
    6. Baehner RL,
    7. Cole FS,
    8. Curnutte JT,
    9. Orkin SH
    . 1986. Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location. Nature322:32–38. doi:10.1038/322032a0.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Rotrosen D,
    2. Yeung CL,
    3. Leto TL,
    4. Malech HL,
    5. Kwong CH
    . 1992. Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. Science256:1459–1462. doi:10.1126/science.1318579.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Clark RA
    . 1999. Activation of the neutrophil respiratory burst oxidase. J Infect Dis179(Suppl 2):S309–S317. doi:10.1086/513849.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Groom QJ,
    2. Torres MA,
    3. Fordham-Skelton AP,
    4. Hammond-Kosack KE,
    5. Robinson NJ,
    6. Jones JD
    . 1996. rbohA, a rice homologue of the mammalian gp91phox respiratory burst oxidase gene. Plant J10:515–522. doi:10.1046/j.1365-313X.1996.10030515.x.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Bánfi B,
    2. Molnár G,
    3. Maturana A,
    4. Steger K,
    5. Hegedûs B,
    6. Demaurex N,
    7. Krause KH
    . 2001. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem276:37594–37601. doi:10.1074/jbc.M103034200.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Cheng G,
    2. Cao Z,
    3. Xu X,
    4. van Meir EG,
    5. Lambeth JD
    . 2001. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene269:131–140. doi:10.1016/S0378-1119(01)00449-8.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Edens WA,
    2. Sharling L,
    3. Cheng G,
    4. Shapira R,
    5. Kinkade JM,
    6. Lee T,
    7. Edens HA,
    8. Tang X,
    9. Sullards C,
    10. Flaherty DB,
    11. Benian GM,
    12. Lambeth JD
    . 2001. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol154:879–891. doi:10.1083/jcb.200103132.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Geiszt M,
    2. Kopp JB,
    3. Várnai P,
    4. Leto TL
    . 2000. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A97:8010–8014. doi:10.1073/pnas.130135897.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Lambeth JD,
    2. Cheng G,
    3. Arnold RS,
    4. Edens WA
    . 2000. Novel homologs of gp91phox. Trends Biochem Sci25:459–461. doi:10.1016/S0968-0004(00)01658-3.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Suh YA,
    2. Arnold RS,
    3. Lassegue B,
    4. Shi J,
    5. Xu X,
    6. Sorescu D,
    7. Chung AB,
    8. Griendling KK,
    9. Lambeth JD
    . 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature401:79–82. doi:10.1038/43459.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Zhang X,
    2. Krause KH,
    3. Xenarios I,
    4. Soldati T,
    5. Boeckmann B
    . 2013. Evolution of the ferric reductase domain (FRD) superfamily: modularity, functional diversification, and signature motifs. PLoS One8:e58126. doi:10.1371/journal.pone.0058126.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. von Rozycki T,
    2. Yen MR,
    3. Lende EE,
    4. Saier MH
    . 2004. The YedZ family: possible heme binding proteins that can be fused to transporters and electron carriers. J Mol Microbiol Biotechnol8:129–140. doi:10.1159/000085786.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Prosser BL,
    2. Ward CW,
    3. Lederer WJ
    . 2011. X-ROS signaling: rapid mechano-chemo transduction in heart. Science333:1440–1445. doi:10.1126/science.1202768.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. O’Neill S,
    2. Brault J,
    3. Stasia MJ,
    4. Knaus UG
    . 2015. Genetic disorders coupled to ROS deficiency. Redox Biol6:135–156. doi:10.1016/j.redox.2015.07.009.
    OpenUrlCrossRef
  22. 22.↵
    1. De Deken X,
    2. Wang D,
    3. Many MC,
    4. Costagliola S,
    5. Libert F,
    6. Vassart G,
    7. Dumont JE,
    8. Miot F
    . 2000. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem275:23227–23233. doi:10.1074/jbc.M000916200.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Bedard K,
    2. Krause KH
    . 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev87:245–313. doi:10.1152/physrev.00044.2005.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Bedard K,
    2. Lardy B,
    3. Krause KH
    . 2007. NOX family NADPH oxidases: not just in mammals. Biochimie89:1107–1112. doi:10.1016/j.biochi.2007.01.012.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Rinnerthaler M,
    2. Büttner S,
    3. Laun P,
    4. Heeren G,
    5. Felder TK,
    6. Klinger H,
    7. Weinberger M,
    8. Stolze K,
    9. Grousl T,
    10. Hasek J,
    11. Benada O,
    12. Frydlova I,
    13. Klocker A,
    14. Simon-Nobbe B,
    15. Jansko B,
    16. Breitenbach-Koller H,
    17. Eisenberg T,
    18. Gourlay CW,
    19. Madeo F,
    20. Burhans WC,
    21. Breitenbach M
    . 2012. Yno1p/Aim14p, a NADPH-oxidase ortholog, controls extramitochondrial reactive oxygen species generation, apoptosis, and actin cable formation in yeast. Proc Natl Acad Sci U S A109:8658–8663. doi:10.1073/pnas.1201629109.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Georgatsou E,
    2. Alexandraki D
    . 1994. Two distinctly regulated genes are required for ferric reduction, the first step of iron uptake in Saccharomyces cerevisiae. Mol Cell Biol14:3065–3073. doi:10.1128/MCB.14.5.3065.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Sanchez-Pulido L,
    2. Rojas AM,
    3. Valencia A,
    4. Martinez-A C,
    5. Andrade MA
    . 2004. ACRATA: a novel electron transfer domain associated to apoptosis and cancer. BMC Cancer4:98. doi:10.1186/1471-2407-4-98.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Roman DG,
    2. Dancis A,
    3. Anderson GJ,
    4. Klausner RD
    . 1993. The fission yeast ferric reductase gene frp1+ is required for ferric iron uptake and encodes a protein that is homologous to the gp91-phox subunit of the human NADPH phagocyte oxidoreductase. Mol Cell Biol13:4342–4350. doi:10.1128/MCB.13.7.4342.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Sumimoto H
    . 2008. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J275:3249–3277. doi:10.1111/j.1742-4658.2008.06488.x.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Pember SO,
    2. Heyl BL,
    3. Kinkade JM,
    4. Lambeth JD
    . 1984. Cytochrome b558 from (bovine) granulocytes. Partial purification from Triton X-114 extracts and properties of the isolated cytochrome. J Biol Chem259:10590–10595.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Cross AR,
    2. Parkinson JF,
    3. Jones OT
    . 1984. The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations. Biochem J223:337–344. doi:10.1042/bj2230337.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Clark RA,
    2. Leidal KG,
    3. Pearson DW,
    4. Nauseef WM
    . 1987. NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem262:4065–4074.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Nozaki M,
    2. Takeshige K,
    3. Sumimoto H,
    4. Minakami S
    . 1990. Reconstitution of the partially purified membrane component of the superoxide-generating NADPH oxidase of pig neutrophils with phospholipid. Eur J Biochem187:335–340. doi:10.1111/j.1432-1033.1990.tb15310.x.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Hashida S,
    2. Yuzawa S,
    3. Suzuki NN,
    4. Fujioka Y,
    5. Takikawa T,
    6. Sumimoto H,
    7. Inagaki F,
    8. Fujii H
    . 2004. Binding of FAD to cytochrome b558 is facilitated during activation of the phagocyte NADPH oxidase, leading to superoxide production. J Biol Chem279:26378–26386. doi:10.1074/jbc.M309724200.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Lord CI,
    2. Riesselman MH,
    3. Gripentrog JM,
    4. Burritt JB,
    5. Jesaitis AJ,
    6. Taylor RM
    . 2008. Single-step immunoaffinity purification and functional reconstitution of human phagocyte flavocytochrome b. J Immunol Methods329:201–207. doi:10.1016/j.jim.2007.10.008.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Nisimoto Y,
    2. Diebold BA,
    3. Cosentino-Gomes D,
    4. Constentino-Gomes D,
    5. Lambeth JD
    . 2014. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry53:5111–5120. doi:10.1021/bi500331y.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Rieske JS
    . 1967. The quantitative determination of mitochondrial hemoproteins. Methods Enzymol10:488–493.
    OpenUrlCrossRef
  38. 38.↵
    1. Juillan-Binard C,
    2. Picciocchi A,
    3. Andrieu JP,
    4. Dupuy J,
    5. Petit-Hartlein I,
    6. Caux-Thang C,
    7. Vivès C,
    8. Nivière V,
    9. Fieschi F
    . 2017. A two-component NADPH oxidase (NOX)-like system in bacteria is involved in the electron transfer chain to the methionine sulfoxide reductase MsrP. J Biol Chem292:2485–2494. doi:10.1074/jbc.M116.752014.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Ellis JA,
    2. Mayer SJ,
    3. Jones OT
    . 1988. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J251:887–891. doi:10.1042/bj2510887.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. O’Donnell VB,
    2. Smith GC,
    3. Jones OT
    . 1994. Involvement of phenyl radicals in iodonium inhibition of flavoenzymes. Mol Pharmacol46:778–785.
    OpenUrlAbstract
  41. 41.↵
    1. Ramirez JL,
    2. Short SM,
    3. Bahia AC,
    4. Saraiva RG,
    5. Dong Y,
    6. Kang S,
    7. Tripathi A,
    8. Mlambo G,
    9. Dimopoulos G
    . 2014. Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities. PLoS Pathog10:e1004398. doi:10.1371/journal.ppat.1004398.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Dunning Hotopp JC
    . 2011. Horizontal gene transfer between bacteria and animals. Trends Genet27:157–163. doi:10.1016/j.tig.2011.01.005.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Ku C,
    2. Martin WF
    . 2016. A natural barrier to lateral gene transfer from prokaryotes to eukaryotes revealed from genomes: the 70 % rule. BMC Biol14:89. doi:10.1186/s12915-016-0315-9.
    OpenUrlCrossRef
  44. 44.↵
    1. Taylor RM,
    2. Burritt JB,
    3. Foubert TR,
    4. Snodgrass MA,
    5. Stone KC,
    6. Baniulis D,
    7. Gripentrog JM,
    8. Lord C,
    9. Jesaitis AJ
    . 2003. Single-step immunoaffinity purification and characterization of dodecylmaltoside-solubilized human neutrophil flavocytochrome b. Biochim Biophys Acta1612:65–75. doi:10.1016/S0005-2736(03)00086-5.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Mizrahi A,
    2. Berdichevsky Y,
    3. Ugolev Y,
    4. Molshanski-Mor S,
    5. Nakash Y,
    6. Dahan I,
    7. Alloul N,
    8. Gorzalczany Y,
    9. Sarfstein R,
    10. Hirshberg M,
    11. Pick E
    . 2006. Assembly of the phagocyte NADPH oxidase complex: chimeric constructs derived from the cytosolic components as tools for exploring structure-function relationships. J Leukoc Biol79:881–895. doi:10.1189/jlb.1005553.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Bloomfield G,
    2. Pears C
    . 2003. Superoxide signalling required for multicellular development of Dictyostelium. J Cell Sci116:3387–3397. doi:10.1242/jcs.00649.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Lardy B,
    2. Bof M,
    3. Aubry L,
    4. Paclet MH,
    5. Morel F,
    6. Satre M,
    7. Klein G
    . 2005. NADPH oxidase homologs are required for normal cell differentiation and morphogenesis in Dictyostelium discoideum. Biochim Biophys Acta1744:199–212. doi:10.1016/j.bbamcr.2005.02.004.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Webb JS,
    2. Givskov M,
    3. Kjelleberg S
    . 2003. Bacterial biofilms: prokaryotic adventures in multicellularity. Curr Opin Microbiol6:578–585. doi:10.1016/j.mib.2003.10.014.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Gennaris A,
    2. Ezraty B,
    3. Henry C,
    4. Agrebi R,
    5. Vergnes A,
    6. Oheix E,
    7. Bos J,
    8. Leverrier P,
    9. Espinosa L,
    10. Szewczyk J,
    11. Vertommen D,
    12. Iranzo O,
    13. Collet JF,
    14. Barras F
    . 2015. Repairing oxidized proteins in the bacterial envelope using respiratory chain electrons. Nature528:409–412. doi:10.1038/nature15764.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Kawahara T,
    2. Quinn MT,
    3. Lambeth JD
    . 2007. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol Biol7:109. doi:10.1186/1471-2148-7-109.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Krogh A,
    2. Larsson B,
    3. von Heijne G,
    4. Sonnhammer EL
    . 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol305:567–580. doi 10.1006/jmbi.2000.4315.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    1. Sievers F,
    2. Wilm A,
    3. Dineen D,
    4. Gibson TJ,
    5. Karplus K,
    6. Li W,
    7. Lopez R,
    8. McWilliam H,
    9. Remmert M,
    10. Söding J,
    11. Thompson JD,
    12. Higgins DG
    . 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol7:539. doi:10.1038/msb.2011.75.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Cowart RE,
    2. Singleton FL,
    3. Hind JS
    . 1993. A comparison of bathophenanthrolinedisulfonic acid and ferrozine as chelators of iron(II) in reduction reactions. Anal Biochem211:151–155. doi:10.1006/abio.1993.1246.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Maghzal GJ,
    2. Krause KH,
    3. Stocker R,
    4. Jaquet V
    . 2012. Detection of reactive oxygen species derived from the family of NOX NADPH oxidases. Free Radic Biol Med53:1903–1918. doi:10.1016/j.freeradbiomed.2012.09.002.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Awai M,
    2. Narasaki M,
    3. Yamanoi Y,
    4. Seno S
    . 1979. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol95:663–673.
    OpenUrlPubMedWeb of Science
  56. 56.↵
    1. Ciccarelli FD,
    2. Doerks T,
    3. von Mering C,
    4. Creevey CJ,
    5. Snel B,
    6. Bork P
    . 2006. Toward automatic reconstruction of a highly resolved tree of life. Science311:1283–1287. doi:10.1126/science.1123061.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Hancock JT,
    2. Jones OT
    . 1987. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J242:103–107. doi:10.1042/bj2420103.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. Green TR,
    2. Wu DE
    . 1985. Detection of NADPH diaphorase activity associated with human neutrophil NADPH-O2 oxidoreductase activity. FEBS Lett179:82–86.
    OpenUrlPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
The NOX Family of Proteins Is Also Present in Bacteria
Christine Hajjar, Mickaël V. Cherrier, Gaëtan Dias Mirandela, Isabelle Petit-Hartlein, Marie José Stasia, Juan C. Fontecilla-Camps, Franck Fieschi, Jérôme Dupuy
mBio Nov 2017, 8 (6) e01487-17; DOI: 10.1128/mBio.01487-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The NOX Family of Proteins Is Also Present in Bacteria
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The NOX Family of Proteins Is Also Present in Bacteria
Christine Hajjar, Mickaël V. Cherrier, Gaëtan Dias Mirandela, Isabelle Petit-Hartlein, Marie José Stasia, Juan C. Fontecilla-Camps, Franck Fieschi, Jérôme Dupuy
mBio Nov 2017, 8 (6) e01487-17; DOI: 10.1128/mBio.01487-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
NADPH oxidases
Streptococcus pneumoniae
Streptococcus pneumoniae
biochemistry
electron transport
flavoenzymes
membrane proteins
metalloenzymes
oxidative stress
phylogenetic analysis

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511